| 33.75 Data as of Jun 06 |  +1.20 / +3.69%Today’s Change | 21.05 Today|||52-Week Range 39.00 | +45.66% Year-to-Date |
| Previous close | 32.55 |
| Today’s open | 32.35 |
| Day’s range | -- - -- |
| Volume | 603,446 |
| Average volume (3 months) | 803,407 |
| Market cap | $3.9B |
| Dividend yield | -- |
| Earnings growth (last year) | +65.67% |
| Earnings growth (this year) | -78.58% |
| Earnings growth (next 5 years) | +96.00% |
| Revenue growth (last year) | +122.43% |
| P/E ratio | NM |
| Price/Sales | 12.95 |
| Price/Book | 17.23 |
| Today’s change | Today’s % change | |
|---|---|---|
| ALKSAlkermes Plc | +1.88 | +6.41% |
| JAZZJazz Pharmaceuticals... | +0.49 | +0.72% |
| ENDPEndo Health Solution... | +1.53 | +4.25% |
| SLXPSalix Pharmaceutical... | +0.10 | +0.17% |
| Next reporting date | July 23, 2013 |
| EPS forecast (this quarter) | -$0.19 |
| Annual revenue (last year) | $210.8M |
| Annual profit (last year) | -$53.8M |
| Net profit margin | -25.51% |
Sector Health Technology |
Industry Biotechnology |
Chairman, President & Chief Executive Officer Clay B. Siegall, PhD |
Chief Operating Officer & Secretary Eric L. Dobmeier |
Corporate headquarters Bothell, Washington |
.
